Dominari Holdings
Dominari Holdings Inc is a biotechnology company focused on developing innovative therapeutic drug platforms, particularly in the fields of oncology and antiviral treatments. The company leverages patented technologies from esteemed universities, including The University of Texas at Austin and Wake Forest University, to advance its pipeline of therapeutics. Its current oncology portfolio includes therapies targeted at pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. In its pursuit of addressing unmet medical needs, Dominari Holdings continually seeks to expand its range of treatments, highlighting its commitment to improving patient outcomes in the field of cancer care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.